↓ Skip to main content

Dove Medical Press

Article Metrics

Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan.

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, May 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
23 Mendeley
Title
Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan.
Published in
ClinicoEconomics and Outcomes Research: CEOR, May 2015
DOI 10.2147/ceor.s85514
Pubmed ID
Authors

Jörg Mahlich, Saito Yoshimichi, Nishi Masamichi

Abstract

The cost of schizophrenia in Japan is high and new long-acting injectable (LAI) antipsychotics might be able to reduce costs by causing a reduction of hospital stays. We aim to estimate budget effects of the introduction of a new 1-month LAI, paliperidone palmitate, in Japan. A budget impact analysis was conducted from a payer perspective. The model took direct costs of illness into account (ie, costs for inpatient and outpatient services, as well as drug costs). The robustness of the model was checked using a sensitivity analysis. According to our calculations, direct total costs of schizophrenia reach 710,500 million yen a year (US$6 billion). These costs decrease to 691,000 million yen (US$5.9 billion) 3 years after the introduction of paliperidone palmitate. From a payer point of view, the introduction of a new treatment for schizophrenia in Japan helps to save resources and is not associated with a higher financial burden.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 30%
Student > Master 4 17%
Other 4 17%
Unspecified 2 9%
Student > Postgraduate 2 9%
Other 2 9%
Unknown 2 9%
Readers by discipline Count As %
Medicine and Dentistry 5 22%
Agricultural and Biological Sciences 3 13%
Unspecified 2 9%
Economics, Econometrics and Finance 2 9%
Business, Management and Accounting 2 9%
Other 5 22%
Unknown 4 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2015.
All research outputs
#4,929,418
of 9,726,436 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#146
of 299 outputs
Outputs of similar age
#105,187
of 226,048 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#11
of 14 outputs
Altmetric has tracked 9,726,436 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 299 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,048 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.